Pages

Showing posts with label Study. Show all posts
Showing posts with label Study. Show all posts

Friday, July 5, 2013

Study: Cannabis Compound Reduces Cigarette Consumption In Tobacco Smokers

Investigators at University College London conducted a double blind pilot study to study the impact of organic non-psychoactive cannabinoid CBD (cannabidiol) versus placebo in 24 tobacco-smoking subjects seeking to quit their addiction. Participants were randomized to receive an inhaler containing CBD (n=12) or placebo (n=12) for one week. Trial investigators instructed subjects to use the inhaler when they felt the urge to smoke.
Abstract

The role of the endocannabinoid system in nicotine addiction is being increasingly acknowledged. We conducted a pilot, randomised double blind placebo controlled study set out to assess the impact of the ad-hoc use of cannabidiol (CBD) in smokers who wished to stop smoking. 24 smokers were randomised to receive an inhaler of CBD (n=12) or placebo (n=12) for one week, they were instructed to use the inhaler when they felt the urge to smoke. Over the treatment week, placebo treated smokers showed no differences in number of cigarettes smoked. In contrast, those treated with CBD significantly reduced the number of cigarettes smoked by ~40% during treatment. Results also indicated some maintenance of this effect at follow-up. These preliminary data, combined with the strong preclinical rationale for use of this compound, suggest CBD to be a potential treatment for nicotine addiction that warrants further exploration.

Investigators concluded in the preliminary data that CBD could be a potential treatment for nicotine addiction and warrants further exploration.

Wednesday, September 19, 2012

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.

ncbi.nlm.nih.gov

This does not imply that weed cures cancer. There are negative and positive effects caused by smoking. However the continued demonization of marijuana could be preventing any number of drug treatments derived form it's component parts.
Abstract
Cannabidiol (CBD), a major non-psychotropic constituent of fiber-type cannabis plant, has been reported to possess diverse biological activities, including anti-proliferative effect on cancer cells. Although CBD is obtained from non-enzymatic decarboxylation of its parent molecule, cannabidiolic acid (CBDA), few studies have investigated whether CBDA itself is biologically active. Results of the current investigation revealed that CBDA inhibits migration of the highly invasive MDA-MB-231 human breast cancer cells, apparently through a mechanism involving inhibition of cAMP-dependent protein kinase A, coupled with an activation of the small GTPase, RhoA. It is established that activation of the RhoA signaling pathway leads to inhibition of the mobility of various cancer cells, including MDA-MB-231 cells. The data presented in this report suggest for the first time that as an active component in the cannabis plant, CBDA offers potential therapeutic modality in the abrogation of cancer cell migration, including aggressive breast cancers.

Thursday, July 12, 2012

UF study shows long-term drug abuse starts with alcohol

University of Florida

GAINESVILLE, Fla. — Alcohol — not marijuana — is the gateway drug that leads adolescents down the path toward more serious substances, a new University of Florida study shows.

The findings may not settle a decades-old debate over how drug abuse begins, but it could help educators and policymakers build more effective drug-prevention programs, said Adam Barry, an assistant professor and researcher in the College of Health and Human Performance.
I'm not really a believer in the correlation/causation stance. I do however believe that if you have a tendency for dependence you will always crave something to fill that hole. The article dose provide evidence that the claim that marijuana is the gateway is false.

Tuesday, May 1, 2012

Marijuana Vaporizer Provides Same Level Of THC, Fewer Toxins, Study Shows

ScienceDaily (May 15, 2007)
A smokeless cannabis-vaporizing device delivers the same level of active therapeutic chemical and produces the same biological effect as smoking cannabis, but without the harmful toxins, according to University of California San Francisco researchers.


Results of a UCSF study, which focuses on delivery of the active ingredient delta-9-tertrahydrocannibinol, or THC, are reported in the online issue of the journal "Clinical Pharmacology and Therapeutics."

Not ground breaking news material in any way shape or form. However I try to post all news related to cannabis that i tend to come across(even when it is five years old).

Tuesday, January 10, 2012

Marijuana Shown to Be Less Damaging to Lungs Than Tobacco

Marijuana Shown to Be Less Damaging to Lungs Than Tobacco | www.ucsf.edu
UCSF-Led Study Compares Effects on Pulmonary Function

A large-scale national study suggests low to moderate use of marijuana is less harmful to users’ lungs than exposure to tobacco, even though the two substances contain many of the same components.
This comprehensive study, led by UCSF and University of Alabama at Birmingham, collected data from more than 5,000 U.S. adults for more than 20 years.
Smoking cigarettes can cause significant lung damage, including respiratory symptoms, chronic obstructive pulmonary disease and lung cancer. It accounts for an estimated 443,000 deaths, or nearly one in every five deaths, each year in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC). Data for the long-term effects of marijuana use on the pulmonary system has been scarce until now.

“We found exactly what we thought we would find in relation to tobacco exposure: a consistent loss of lung function with increasing exposure,” said the paper’s lead author, Mark Pletcher, MD, MPH, associate professor in the Division of Clinical Epidemiology at UCSF. “We were, however, surprised that we found such a different pattern of association with marijuana exposure.”
Mark Pletcher, MD, MPHIn a paper published today in the Journal of American Medical Association (JAMA), researchers analyzed the relationship between current and lifetime exposure to marijuana and pulmonary function. The Coronary Artery Risk Development in Young Adults (CARDIA) study collected medical data from 5,115 men and women in four U.S. cities from 1985 to 2006.
They measured air flow rate – the speed in which a person can blow out air – and lung volume, which is the amount of air a person is capable of holding, typically about six liters of air for an adult male. Lung function was measured using a common medical device called a spirometer that measures air flow when the participant breathes in and out.
“Essentially with tobacco, the more you use, the more loss you have with both of the indicators, air flow rate and lung volume,” said the paper’s last author Stefan Kertesz, MD, MSc, associate professor in the Division of Preventive Medicine at the University of Alabama at Birmingham School of Medicine and the Birmingham VA Medical Center. “There’s a straight-line relationship: the more you use, the more you lose.”
The same was not true with marijuana use. Air flow rate increased rather than decreased with increased exposure to marijuana up to a certain level.
“An important factor that helps explain the difference in effects from these two substances is the amount of each that is typically smoked,” Pletcher said. “Tobacco users typically smoke ten to 20 cigarettes/day, and some smoke much more than that. Marijuana users, on average, smoke only two to three times a month, so the typical exposure to marijuana is much lower than for tobacco.”
“And marijuana is one where a lot of people dabble with it in their late teens and 20s, and some people continue with relatively low levels for a long period of time,” Kertesz added.

Heavy Marijuana Use May Take Toll

Although there was a suggestion that very heavy use of marijuana might be taking a toll on the lungs, the researchers could not get reliable estimates of the effects of very heavy marijuana exposure, as such smokers were relatively rare in the study population.
All participants in the study began as young, healthy adults 18 to 30 years old from four communities: Oakland, Chicago, Minneapolis and Birmingham. They volunteered to be part of this long-term medical research study, agreeing that their data could be used to explore questions, including about tobacco and marijuana use.
Researchers believe the results can supplement the growing body of knowledge about beneficial aspects of low to moderate marijuana use in controlling pain, stimulating appetite, elevating mood and managing other chronic symptoms.
“Our findings suggest that occasional use of marijuana for these or other purposes may not be associated with adverse consequences on pulmonary function,” Pletcher said. “On the other hand, our findings do suggest an accelerated decline in pulmonary function with heavier use – either very frequent use or frequent use over many years – and a resulting need for caution and moderation when marijuana use is considered.”
Pletcher is the lead author of the paper; co-authors are Eric Vittinghoff, PhD, and Feng Lin, MS; of the UCSF Department of Epidemiology and Biostatistics; Ravi Kalhan, MD, MS, of the Divison of Pulmonary and Critical Care Medicine at Northwestern University Feinberg School of Medicine; Stephen Sidney, MD, MPH, of Kaiser Permanente of Northern California, Oakland; Joshua Richman, MD, PhD, Monika Safford, MD, and Stefan Kertesz, MD, of the University of Alabama at Birmingham and Veterans Affairs Medical Center.
The study was supported by funds from the National Heart Lung Blood Institute.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

Thursday, November 3, 2011

Study examines nicotine as a gateway drug

A landmark study in mice identifies a biological mechanism that could help explain how tobacco products could act as gateway drugs, increasing a person's future likelihood of abusing cocaine and perhaps other drugs as well, according to the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The study is the first to show that nicotine might prime the brain to enhance the behavioral effects of cocaine.
Read more: Study examines nicotine as a gateway drug

Monday, September 12, 2011

Smoking marijuana not linked to obesity: study

via Smoking marijuana not linked to obesity: study | Reuters
(Reuters) - Anybody who's smoked marijuana knows about "the munchies," that desire to eat everything within reach. But a study from France has found that, surprisingly, pot smokers are actually less likely than non-smokers to pack on weight.

Using data covering more than 50,000 U.S. adults, researchers headed by Yann Le Strat, a psychiatrist at the Louis-Mourier Hospital in Colombes, France, found that roughly 14 percent to 17 percent of the people reporting that they smoked pot at least three days per week were obese.

That compared with a 22 to 25 percent obesity rate among people who said they had not used pot in the past 12 months.

Sunday, February 20, 2011

No evidence that ecstasy causes brain damage


Alcohol and tobacco are more dangerous but are perfectly legal and socially acceptable just about everywhere, why is it that other drugs are treated differently.
There is no evidence that ecstasy causes brain damage, according to one of the largest studies into the effects of the drug. Too many previous studies made over-arching conclusions from insufficient data, say the scientists responsible for the research, and the drug's dangers have been greatly exaggerated.

The finding will shock campaigners who have claimed ecstasy poses a real risk of triggering brain damage. They have argued that it can induce memory loss, decrease cognitive performance and has long-lasting effects on behaviour.
The full article: Ecstasy does not wreck the mind, study claims